The effects of an oestrogen-free, desogestrel-containing oral contraceptive in women with cyclical symptoms: Results from two studies on oestrogen-related symptoms and dysmenorrhoea

European Journal of Contraception and Reproductive Health Care

Volumn 12, Issue 4, 2007, Pages 354-361

  Ahrendt, Hans Joachim ^a   Karck, Ulrich ^b   Pichl, Tanja ^b   Mueller, Thomas ^b   Ernst, Uwe ^b  

^a Frauenklinik ^*

^b Organon GmbH   (Germany)

Author keywords

Cyclical symptoms; Desogestrel; Dysmenorrhoea; Observational study; Oestrogen free; Oral contraceptive; Side effects

Indexed keywords

ANALGESIC AGENT; DESOGESTREL; ESTROGEN;

ACNE; ADULT; AMENORRHEA; ARTICLE; BLEEDING; BREAST TENDERNESS; CONTROLLED STUDY; DERMATITIS; DRUG USE; DRY SKIN; DYSMENORRHEA; EDEMA; FEMALE; GERMANY; HEADACHE; HUMAN; HYPERTRICHOSIS; MAJOR CLINICAL STUDY; MENORRHAGIA; NAUSEA; OBSERVATIONAL STUDY; OLIGOMENORRHEA; ORAL CONTRACEPTION; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; BREAST; CONTRACEPTIVES, ORAL, HORMONAL; CONTRACEPTIVES, ORAL, SYNTHETIC; DESOGESTREL; DYSMENORRHEA; EDEMA; ESTROGENS; FEMALE; HEADACHE; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; NAUSEA; PATIENT SATISFACTION; PROSPECTIVE STUDIES;

EID: 36348945321     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.1080/13625180701536771     Document Type: Article

References (21)

1. Wu O, Robertson L, Langhorne P, et al. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thromb Haemost 2005;94:17-25.
2. McCann MF, Potter LS. Progestogen-only oral contraception: a comprehensive review. Contraception 1994;50(Suppl 1):S1-S198.
3. Hatcher RA, Guillebaud J. The Pill: Combined oral contraceptives. In Hatcher RA, et al., eds. Contraceptive technology, 17th edn. New York: Ardent Media, Inc., 1998:405-60.
4. Silberstein SD. Hormone-related headache. Med Clin North Am 2001;85:1017-35.
5. Chi I. The safety and efficacy of progestin-only contraceptives - An epidemiological perspective. Contraception 1993;47:1-21.
6. Fotherby K, Caldwell ADS. New progestogens in oral contraception. Contraception 1994;49:1-32.
7. Kloosterboer HJ, Vonk-Noordergraaf CA, Turpijn EW. Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives. Contraception 1988;38:325-32.
8. Rice CF, Killick SR, Dieben T, et al. A comparison of the inhibition of ovulation achieved by desogestrel 75 mcg and levonorgestrel 30 mcg daily. Hum Reprod 1999;14:982-5.
9. Korver T, Klipping C, Heger-Mahn D, et al. Maintenance of ovulation inhibition with the 75 μg desogestrel-only contraceptive pill after scheduled 12-hour delays in tablet-intake. Contraception 2005;71:8-13.
10. Korver T, Dieben T, Vree M, et al. A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 mcg/day or levonorgestrel 30 mcg/day. Eur J Contracept Reprod Health Care 1998;3:169-78.
11. Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol 2006;108:428-41.
12. Proctor ML, Roberts H, Farquhar CM. Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhea. Cochrane Database Syst Rev 2001;(4):CD002120.
13. Bieglmayer C, Hofer G, Kainz C, et al. Concentrations of various arachidonic acid metabolites in menstrual fluid are associated with menstrual pain and are influenced by hormonal contraceptives. Gynecol Endocrinol 1995;9:307-12.
14. Hendrix SL, Alexander NJ. Primary dysmenorrhoea treatment with a desogestrel-containing low-dose oral contraceptive. Contraception 2002;66:393-9.
15. Edelman A, Gallo MF, Nichols MD, et al. Continuous versus cyclic use of combined oral contraceptives for contraception: Systematic Cochrane review of randomised controlled trials. Hum Reprod 2006;21:573-8.
16. Wiegratz I, Kuhl H. Long-cycle treatment with oral contraceptives. Drugs 2004;64:2447-62.
17. Lay CL, Mascellino AM. Menstrual migraine: diagnosis and treatment. Curr Pain Headache Rep 2001;5:195-9.
18. Redmond G, Godwin AJ, Olson W, et al. Use of placebo controls in an oral contraceptive trial: methodological issues and adverse event incidence. Contraception 1999;60:81-5.
19. Fraser IS. The promise and performance of progestogens as contraceptives. Reprod Fertil Dev 2001;13:713-21.
20. Porter C, Rees MCP. Bleeding problems and progestogen-only contraception. J Fam Plann Reprod Health Care 2002;28:178-81.
21. Collaborative Study Group on the desogestrel-containing progestogen-only Pill. A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 mcg/day or levonorgestrel 30 mcg/day. Eur J Contracept Reprod Health Care 1998;3:169-78.